Current Affairs · Biomedical Developments and Health

With reference to Lenacapavir (LEN), consider the following statements: I. It has been approved by the United States Food and Drug Administration (FDA) for use in HIV prevention as pre-exposure prophylaxis (PrEP). II. It is an injectable PrEP regimen that is administered twice a year and is seen as a more convenient alternative to daily oral PrEP. III. It completely cures HIV infection by eliminating the virus from the body. How many of the statements given above are correct?